Cargando…
Patient related outcomes in a real life prospective follow up study: Allergen immunotherapy increase quality of life and reduce sick days
BACKGROUND: One fourth of the adult population in Europe suffer from respiratory allergy. Subcutaneous-allergen-specific-immunotherapy (SCIT) has long-term disease modifying effect on disease specific Health-Related Quality of Life (HRQoL). The purpose of this study was to assess the effect of SCIT...
Autores principales: | Petersen, Karin D, Kronborg, Christian, Larsen, Jørgen N, Dahl, Ronald, Gyrd-Hansen, Dorte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846409/ https://www.ncbi.nlm.nih.gov/pubmed/24229439 http://dx.doi.org/10.1186/1939-4551-6-15 |
Ejemplares similares
-
Characteristics of patients receiving allergy vaccination: to which extent do socio-economic factors play a role?
por: Petersen, Karin Dam, et al.
Publicado: (2011) -
Adherence to Subcutaneous Allergen Immunotherapy in Southeast Turkey: A Real-Life Study
por: Tat, Tugba S.
Publicado: (2018) -
Real-life evidence in allergen immunotherapy: Moving forward with mHealth apps
por: Sousa-Pinto, Bernardo, et al.
Publicado: (2023) -
Real‐life data on inactivated COVID‐19 vaccination in patients with subcutaneous allergen immunotherapy
por: Xu, Yingyang, et al.
Publicado: (2022) -
Allergen immunotherapy in MASK‐air users in real‐life: Results of a Bayesian mixed‐effects model
por: Sousa‐Pinto, Bernardo, et al.
Publicado: (2022)